Protease mutations emerging on darunavir in protease inhibitor‐naïve and experienced patients in the...
Protease mutations emerging on darunavir in protease inhibitor‐naïve and experienced patients in the UK
About this item
Full title
Author / Creator
Publisher
Switzerland: International AIDS Society
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: International AIDS Society
Subjects
More information
Scope and Contents
Contents
Introduction
Darunavir (DRV) is a preferred agent in treatment guidelines for ART‐naïve and experienced patients [1]. It is considered to have a high genetic barrier to resistance and 11 resistance‐associated mutations (RAMs) are recognized by IAS‐USA [2]. These have largely been identified by analyses examining the correlation between baseline...
Alternative Titles
Full title
Protease mutations emerging on darunavir in protease inhibitor‐naïve and experienced patients in the UK
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4225433
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4225433
Other Identifiers
ISSN
1758-2652
E-ISSN
1758-2652
DOI
10.7448/IAS.17.4.19739
